| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 |
| filingDate |
1995-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d88fbc7431573f66b31d75eb805843a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e77fd72ba6683727cf2ee1e0fab8237e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0291b219dd888e7023772693c91a538d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9caeb4a5cd4e00c54dcb5c8cf51088d |
| publicationDate |
1996-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2294047-A |
| titleOfInvention |
Synthetic peptides for use as epitopes specific for HIV |
| abstract |
There are disclosed selected principal neutralization synthetic epitopes which bind the Human Immunodeficiency Virus (HIV) neutralising antibody 19b which antibody is specific for the HIV gp120. The epitopes are identified from phage epitope libraries using the antibody. The epitopes can be conjugated to immunological carriers such as the outer membrane proteosome complex of Noisseria or an immuno-enhancer sequence such as Hepatitis B core. The conjugate may comprise one epitope sequence or multiple sequences. The conjugates are useful for vaccination against Acquired Immune Deficiency Syndrome (AIDS) or Aids-Related Complex as well as in the production of other HIV-specific broadly neutralizing antibodies for passive immunity against AIDS or Aids-Related complex. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9744469-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-719929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6428792-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9744469-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6514731-B1 |
| priorityDate |
1994-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |